研發與技術
R&D and Technology
2024-Current status and future directions for the development of human papillomavirus vaccines
2024-06-20
999+
學術論著
上一篇：2024-Efficacy safety and genomic analysis of SCT200 an anti-EGFR monoclonal antibody in patients with fluorouracil irinotecan and oxaliplatin refractory RAS and BRAF wild-type static
下一篇：2024-BiSpec Pairwise AI Guiding the Selection of Bispecific Antibody Target Combinations with pairwise learning and GPT augmentation
最新資訊
-
2024-SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma A randomized phase 3 trial
2024-06-20 -
2024-Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
2024-05-06 -
2024-Immunogenicity of Tetravalent Protein Vaccine against SARS-CoV-2 EG.5 Subvaraint A Phase 2 Trial
2024-02-08 -
2024-Finotonlimab with chemotherapy in recurrent or static head and neck cancer a randomized phase 3 trial
2024-06-02